A meta-analysis of six studies involving 1527 patients with COVID-19 found that cardiovascular metabolic diseases, including hypertension (17.1%), cardiac-cerebrovascular disease (16.4%), and diabetes (9.7%), were prevalent among patients. ICU/severe cases had significantly higher rates of these conditions compared to non-ICU/severe cases, with hypertension, cardiac-cerebrovascular disease, and diabetes being about two, three, and two times more common, respectively. At least 8.0% of patients experienced acute cardiac injury, with ICU/severe cases having 13 times higher incidence. The study suggests that patients with cardiovascular metabolic diseases are at greater risk of severe illness and poor prognosis from COVID-19. Additionally, the virus may exacerbate cardiac damage. The analysis highlights the need for further research to better understand the relationship between cardiovascular diseases and COVID-19. The study also notes that while the prevalence of hypertension and diabetes in COVID-19 patients is similar to the general population, the incidence of cardiac-cerebrovascular disease is significantly higher. The findings indicate that patients with cardiovascular diseases are more likely to develop severe cases of COVID-19, and that the virus can cause significant cardiac injury. The study concludes that cardiovascular metabolic diseases may increase the risk of severe illness and poor outcomes from COVID-19, and that the virus can also worsen cardiac damage.A meta-analysis of six studies involving 1527 patients with COVID-19 found that cardiovascular metabolic diseases, including hypertension (17.1%), cardiac-cerebrovascular disease (16.4%), and diabetes (9.7%), were prevalent among patients. ICU/severe cases had significantly higher rates of these conditions compared to non-ICU/severe cases, with hypertension, cardiac-cerebrovascular disease, and diabetes being about two, three, and two times more common, respectively. At least 8.0% of patients experienced acute cardiac injury, with ICU/severe cases having 13 times higher incidence. The study suggests that patients with cardiovascular metabolic diseases are at greater risk of severe illness and poor prognosis from COVID-19. Additionally, the virus may exacerbate cardiac damage. The analysis highlights the need for further research to better understand the relationship between cardiovascular diseases and COVID-19. The study also notes that while the prevalence of hypertension and diabetes in COVID-19 patients is similar to the general population, the incidence of cardiac-cerebrovascular disease is significantly higher. The findings indicate that patients with cardiovascular diseases are more likely to develop severe cases of COVID-19, and that the virus can cause significant cardiac injury. The study concludes that cardiovascular metabolic diseases may increase the risk of severe illness and poor outcomes from COVID-19, and that the virus can also worsen cardiac damage.